Discover trends, market shifts, and competitive outlooks for the non-injectable insulin industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

What is the Projected CAGR for the Non-injectable Insulin Market Size from 2025 to 2034?

The market size for non-injectable insulin has witnessed a swift expansion in recent times. The market is projected to inflate from $1.92 billion in 2024 to $2.16 billion in 2025, reflecting a compound annual growth rate (CAGR) of 12.1%. This significant surge during the historic period can be credited to the increased patient compliance, addressing needle phobia, improved quality of life, easier application process, and consistent control of blood sugar levels.

The market for non-injectable insulin is anticipated to experience swift expansion in the next few years, reaching a worth of $3.17 billion in 2029 with a compounded annual growth rate (CAGR) of 10.1%. The factors contributing to this projected growth during the forecast period include ongoing focus on patient adherence, lasting solutions for needle phobia, constant enhancement of quality of life and safety, and minimized risk of injuries and infections. Key trends during this period include advancements in technology, development of tech-based solutions, integration of digital health, application of nanotechnology, and usage of combination therapies.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13888&type=smp

What are the Fundamental Drivers and Innovations Shaping the Non-injectable Insulin Market?

The upward trend in obesity and diabetes disorders is forecasted to boost the advancement of the non-injectable insulin market. Obesity, a health condition distinguished by an overabundance of body fat usually due to disparity between energy consumption and energy use, and diabetes mellitus, more simply known as diabetes, which is a set of metabolic diseases categorized by enduringly high blood sugar levels. Non-injectable insulin is employed to take care of diabetes and obesity, with the prospective for improving management by confronting obstacles to insulin treatment, proposing likely weight management advantages, and offering simpler therapy options. For instance, the World Heart Federation, a NGO located in Switzerland, indicated in 2022 that obesity rates around the globe are expected to skyrocket, with around 2.3 billion people in 2021, encompassing children and adults, struggling with overweight and obesity. This is anticipated to escalate to 2.7 billion by 2025. Additionally, in April 2023, as per a study by the British Diabetic Association, the UK’s diabetes charity, about 4.3 million people in the UK are diabetic, while over 2.4 million are at a high threat of developing type 2 diabetes. The registration rates for 2021-22 saw an increase of 148,951 as compared to the preceding year. Hence, the escalating issues of obesity and diabetes are fuelling the growth of the non-injectable insulin market.

How Is the Non-injectable Insulin Market Segmented?

The non-injectable insulin market covered in this report is segmented –

1) By Type: Synthetic Insulin, Semi Synthetic Insulin

2) By Product: Pills, Sprays, Other Products

3) By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Drug Stores

Subsegments:

1) By Synthetic Insulin: Rapid-Acting Synthetic Insulin, Short-Acting Synthetic Insulin, Intermediate-Acting Synthetic Insulin, Long-Acting Synthetic Insulin

2) By Semi-Synthetic Insulin: Modified Insulin Analogs, Combination Insulins, Biosimilar Insulins, Insulin With Extended Release Formulations

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=13888&type=smp

Which Regions Are Driving the Next Phase of the Non-injectable Insulin Market Growth?

North America was the largest region in the non-injectable insulin market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the non-injectable insulin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Key Trends Are Shaping the Future of the Non-injectable Insulin Market?

Leading firms in the non-injectable insulin market are prioritizing innovative enhancements in drug delivery mechanisms, such as a needle-free oral insulin spray. This shift aims to better the lives of individuals managing their diabetes through numerous insulin shots. A needle-free insulin spray offers a pain-free substitute for controlling blood glucose levels, presenting a more convenient option as it can be sprayed directly into the mouth. For instance, in November 2023, Ozulin, an oral insulin spray, was introduced by NiedlFree Technologies, a technological platform based in India. The spray aims to facilitate a more manageable solution for people with diabetes, mainly those who find traditional injection-based insulin methods tough. If approved, Ozulin has the capacity to revolutionize diabetic treatment by offering a more convenient and painless substitute for insulin injections.

View the full report here:

https://www.thebusinessresearchcompany.com/report/non-injectable-insulin-global-market-report

How Is the Non-injectable Insulin Market Defined and What Are Its Core Parameters?

Non-injectable insulin is a type of insulin that can be administered into the body without the need for injection. These non-injectable forms of insulin aim to offer alternatives to traditional injections, making diabetes management more accessible and potentially improving the overall quality of life for individuals with diabetes.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13888

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

[KClientError] [REQ_ERR: OPERATION_TIMEDOUT] [KTrafficClient] Something is wrong.